MicroRNAs (miRNAs) are small, non-coding RNA molecules that play an important role in the posttranscriptional regulation of mRNA. These molecules have been the subject of growing interest as they are believed to control the regulation of a large number of genes, including those expressed in the brain. Evidence suggests that miRNAs could be involved in the pathogenesis of neuropsychiatric disorders. Alterations in metabolic enzymes of the polyamine system have been reported to play a role in predisposition to suicidal behaviour. We have previously shown the expression of the polyamine genes SAT1 and SMOX to be down-regulated in the brains of suicide completers. In this study, we hypothesized that the dysregulation of these genes in depressed suicide completers could be influenced by miRNA posttranscriptional regulation. Using a stringent target prediction analysis, we identified several miRNAs that target the 3'UTR of SAT1 and SMOX. We profiled the expression of 10 miRNAs in the prefrontal cortex (BA44) of suicide completers (N = 15) and controls (N = 16) using qRT-PCR. We found that several miRNAs showed significant up-regulation in the prefrontal cortex of suicide completers compared to psychiatric healthy controls. Furthermore, we demonstrated a significant correlation between these miRNAs and the expression levels of both SAT1 and SMOX. Our results suggest a relationship between miRNAs and polyamine gene expression in the suicide brain, and postulate a mechanism for SAT1 and SMOX down-regulation by post-transcriptional activity of miRNAs.
Introduction
Major depressive disorder (MDD), a mood disorder affecting millions of people worldwide, is characterized by lack of interest and pleasure in daily activities, feelings of worthlessness, and recurrent thoughts of death and suicide (Schmidt et al., 2011) . Suicidal behaviours represent the most devastating consequence of this disorder. Although significant progress has been made over the last decades investigating the neurobiological underpinnings of suicide , the specific cellular and molecular mechanisms have yet to be understood . To this day, most studies on MDD and suicide have been focused on monoaminergic metabolism and neurotransmission, but recent evidence suggests that other molecular pathways, such as glutamatergic neurotransmission and the polyamine stress-response system, may also play a role (Fiori and Turecki, 2010a; Fiori et al., 2011) .
Changes in the expression of the rate-limiting enzymes of polyamine metabolism have been observed in MDD and suicide (Klempan et al., 2009b) . Studies have previously shown the expression of the polyamine genes spermidine/spermine N 1 -acetyltransferase 1 (SAT1) (Sequeira et al., 2006; Fiori et al., 2009; Guipponi et al., 2009; Fiori and Turecki, 2010b) and spermine oxidase (SMOX) (Sequeira et al., 2007; Klempan et al., 2009a; Fiori and Turecki, 2010c) to be down-regulated in the brains of suicide completers. Subsequent studies in both suicide attempters and completers have suggested that part of the down-regulation of SAT1 may be explained by a polymorphism in its gene promoter (Sequeira et al., 2006; Fiori et al., 2009) . With respect to SMOX, regulatory genetic variants and epigenetic mechanisms do not seem to explain the lower expression levels observed in suicide (Fiori and Turecki, 2010c) . Accumulating evidence indicates that, in addition to traditional regulatory mechanisms, noncoding RNA transcripts act as fine-tuners and on/off switches to regulate gene expression patterns (Chu and Rana, 2007; Almeida et al., 2011; Pritchard et al., 2012; Qureshi and Mehler, 2012) .
Since their discovery nearly two decades ago, microRNAs (miRNAs) have revolutionized our understanding of the regulation of gene expression in all organs, including the brain (Montano, 2011; Shruti et al., 2011; Omran et al., 2012) . Through posttranscriptional activity, these non-coding, small, single stranded, 17-22-base RNA transcripts regulate the expression of gene networks by one of two mechanisms: mRNA degradation or transcriptional repression (Gu and Kay, 2010) . MiRNAs have been implicated in various aspects of cerebral function, including neurogenesis and synaptic plasticity (Dwivedi, 2011; Serafini et al., 2012) . Similarly, miRNAs have been investigated in the context of cerebral dysfunctions, such as those documented in psychiatric disorders (Forero et al., 2010; Dwivedi, 2011; O'Connor et al., 2012) . Interestingly, miRNAs have already been implicated in schizophrenia (Perkins et al., 2007; Beveridge et al., 2008 Beveridge et al., , 2010 Kim et al., 2010; Moreau et al., 2011) , bipolar disorder Zhou et al., 2009; Kim et al., 2010; Moreau et al., 2011; Rong et al., 2011) , and MDD (Saus et al., 2010; Tatro et al., 2010; Xu et al., 2010; Maussion et al., 2012; Smalheiser et al., 2012) , as well as in response to antidepressant treatment (Zhou et al., 2009; Baudry et al., 2010; Bocchio-Chiavetto et al., 2012) .
The aim of the present study was to test the hypothesis that miRNAs are associated with the observed down-regulation of polyamine genes in the suicide brain. SAT1 and SMOX expression levels were measured in the prefrontal cortex of depressed suicide completers and sudden-death controls, as were expression levels of several miRNAs predicted to target the 3′UTR of both genes. Our results suggest that post-transcriptional miRNA activity likely contributes to polyamine dysregulation in the suicide brain.
Methods

Human brain samples
Ethics approval for this study was obtained from the research ethics board at the Douglas Mental Health University Institute. Prefrontal cortex (Brodmann area 44; BA44) tissue samples were obtained in collaboration with the Quebec Coroner's Office and the Quebec Suicide Brain Bank (Douglas Institute). This region was chosen on the basis that it has been previously implicated in MDD and suicide by postmortem and neuroimaging approaches (Gurevich and Joyce, 1997; Raust et al., 2007; Meyer et al., 2008; Klempan et al., 2009a; Sequeira et al., 2009; van Heeringen et al., 2011; Fiori and Turecki, 2012; Gross et al., 2013) . The two subject groups consisted of suicide completers with a history of MDD (N = 15) and age-matched sudden-death controls (N = 16), based on DSM-IV criteria. All individuals were males and of French-Canadian origin, a homogenous population with a well identified founder effect (Labuda et al., 1996) . Psychological autopsies were performed for both groups, and controls had no history of suicidal behaviour or of major psychiatric disorders (Table 1 ). Brain samples were matched for pH and refrigeration delay. The latter refers to the time elapsed between time of death and refrigeration of the body at the morgue.
RNA extraction
Total RNA (including miRNA fraction) was isolated from frozen brain tissues using the miRNeasy Mini Kit protocol (Qiagen, Canada) with on column DNase treatment and no other modifications. RNA and miRNA yield and quality were determined using the Nanodrop 1000 (Thermo Scientific, USA) and Agilent 2100 Bioanalyzer (Agilent Technologies, USA), respectively. The average RNA Integrity Number (RIN) value for all our samples was 6.4. Table 1 . Prefrontal cortex brain tissue (BA44) was obtained from the Quebec Suicide Brain Bank. All individuals were male and groups were matched for age, pH and refrigeration delay. Psychological autopsies were performed post-mortem on both cases (n = 15) and controls (n = 16) based on DSM-IV criteria. The control group had no history of suicidal behavior or major mood or psychotic disorders
Controls Suicides
Sample (N) 1 6 1 5 Age 39.8 ± 3.3 37.9 ± 2.8 Brain pH 6.6 ± 0.1 6.6 ± 0.1 Refrigeration delay 23.8 ± 3.1 29.3 ± 3.7 RIN 6.4 ± 0.1 6.4 ± 0.2
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total mRNA was reverse transcribed using M-MLV reverse transcriptase and oligo(dT)16 primers. MiRNA was reverse transcribed using TaqMan RT-PCR microRNA assays according to the manufacturer's instructions (Life Technologies, Canada). Expression levels were calculated using the Absolute Quantitation (AQ) standard curve method with GAPDH and RNU6B as endogenous controls, for mRNA and miRNA, respectively. Real-time PCR reactions were run in quintuplets using the ABI 7900HT Fast RealTime PCR System, and data was collected using the Sequence Detection System (SDS) software (Life Technologies, Canada).
miRNA target prediction
Although many bioinformatic predictor algorithms have been developed for identifying potential miRNA/ mRNA interactions, direct comparisons between prediction sets is sometimes difficult (Maziere and Enright, 2007; Yue et al., 2009) . Briefly, each algorithm is based on unique assumptions or principles such as, seed sequence complementarity, free energy of duplex formation, cross-species conservation, and local sequence context (Long and Lahiri, 2012) . In order to minimize type I and II errors generated by each individual database, we identified miRNAs targeting the 3′UTR of the SAT1 and SMOX genes by conservatively cross-referencing the top five prediction algorithms : miRWalk (Dweep et al., 2011) , microRNA.org (Betel et al., 2008) , RNA22 (Miranda et al., 2006) , RNA Hybrid (Kruger and Rehmsmeier, 2006) , and TargetScan (Lewis et al., 2005) . Only miRNAs expressed in human brain and predicted by all five databases were chosen (Table 2) .
Data analysis
Outlier analysis was performed before any other statistical computation. The Shapiro-Wilk normality test, unpaired t-test, Pearson's correlation coefficients, and their statistical significance were calculated using GraphPad Prism5 and SPSS 20.
Results
Expression of SAT1 and SMOX
We first investigated the mRNA expression of SAT1 and SMOX genes in BA44 of suicide completers and controls using qRT-PCR. In line with previous reports, we found a significant down-regulation of both genes in suicide completers compared to controls (SAT1, p < 0.01, FC: 0.73; SMOX, p < 0.01, FC: 0.51) (Fig. 1) .
miRNA target prediction analysis
A total of 219 miRNAs were predicted to bind to the 3′UTR of SAT1, while 213 were predicted for SMOX (Supplemental Material Tables S1 and S2 ). Only miRNAs predicted by all five algorithms and expressed in human brain were chosen, yielding 18 miRNAs for SAT1 and 19 for SMOX (Supplemental Material  Table S3 ). Upon cross-referencing the lists for SAT1 miR-124a, miR-139-5p, miR-195, miR-198, miR-320c, miR-33b, miR-34a, miR-34c-5p , miR-497 and miR-873 (Table 2) .
Expression of predicted miRNA targets
We profiled the expression levels of the 10 miRNAs predicted to target the 3′UTR of SAT1 and SMOX, using qRT-PCR. All miRNA data were normalized to the endogenous control RNU6B. BA44 expression levels of miR-34c-5p (p < 0.01, FC: 2.56), miR-139-5p (p < 0.01, FC: 1.84), miR-195 (p < 0.01, FC: 1.68), and miR-320c (p < 0.01, FC: 1.95) showed a significant up-regulation in suicide completers as compared to controls (Fig. 2) . Furthermore, we performed a correlation analysis between mRNA expression levels of SAT1 and SMOX and miRNA expression of the predicted targets. We found a significant negative correlation between the expression levels of SAT1 and two miRNA targets: miR-34c-5p (p < 0.05, Pearson's r=−0.37, R 2 = 0.14) and miR-320c (p < 0.01, Pearson's r=−0.53, R 2 = 0.28) (Fig. 3) . In addition, we found a significant negative correlation between SMOX mRNA expression levels and the expression levels of two predicted miRNA targets: miR-139-5p (p < 0.05, Pearson's r=−0.37, R 2 = 0.14), miR-320c (p < 0.01, Pearson's r=−0.52, R 2 = 0.27) (Fig. 4) . . miRNA expression in prefrontal cortex (BA44). Expression levels of ten miRNAs predicted to target the 3'UTR of SAT1 and SMOX genes in suicide completers (n = 15) and controls (n = 16) were confirmed by TaqMan qRT-PCR (normalized to endogenous control RNU6B), using the absolute quantitation (AQ) standard curve method.
Discussion
Little evidence has so far been reported to support roles for traditional genetic or epigenetic factors in regulating the expression of SAT1 and SMOX in the brains of depressed suicide completers. In this study, we investigated miRNAs as potential post-transcriptional agents affecting SAT1 and SMOX regulation. In agreement with previous reports, we found a significant down-regulation in the expression levels of SAT1 and SMOX in the brains of suicide completers. The consistency of our results for these two genes, using an independent sample set, strengthens the validity of our previous findings and highlights their significance for the neurobiology of suicide.
In order to identify miRNAs that can regulate the expression of SAT1 and SMOX, we performed a stringent target prediction analysis, using several available prediction algorithms. To date, there are no clear guidelines on how to identify miRNA targeting specific mRNA sequences. Although there are many target prediction algorithms that are easily accessed and generally successful in identifying likely target interactions, recent analyses on both protein and RNA expression have shown that bioinformatic predictions capture high levels of false positives and negatives (Long and Lahiri, 2012) . In order to minimize these types of errors, we used the conservative approach of cross-referencing the top five prediction algorithms in the field to select our candidates. Functional studies on miR-139-5p, miR-195, miR-320c and miR-34c-5p have been mainly conducted in the context of cancer and neurodegenerative disorders. Previous investigations of these miRNAs have shown that they are involved in the regulation of cell apoptosis, proliferation, migration and invasion (Lopez and Alvarez-Salas, 2011; Skalsky and Cullen, 2011; Bhattacharya et al., 2012; Miles et al., 2012; Wu et al., 2012) , and suggested that they are implicated in Alzheimer's disease (Zhu et al., 2012 ), Parkinson's disease (Minones-Moyano et al., 2011) and Prion diseases (Saba et al., 2008) . However, little is known that could help us hypothesize about their potential role in neuropsychiatric disorders. Nevertheless, in 2009, is associated with schizophrenia and reported a relationship between miR-195 and the brain-derived neurotrophic factor (BDNF) protein in post-mortem brain tissues (Mellios et al., 2009 ). Although we found a significant up-regulation of miR-195 in the brains of suicide completers, we did not find a significant correlation with either SAT1 or SMOX. Based on our results and numerous reports of a down-regulation of BDNF in the blood of depressed patients (Lopez et al., 2012) and the brains of suicide completers , it would be worth further investigating the potential role of miR-195 in MDD and suicide in future studies.
In addition to miR-195, miR-34c-5p has also been recently suggested to play a role in brain disorders. Bocchio-Chiavetto et al. reported a down-regulation of miR-34c-5p in the blood of depressed patients after antidepressant treatment (Bocchio-Chiavetto et al., 2012) . Other studies have shown that miR-34c is involved in animal models of stress-induced anxiety (Haramati et al., 2011) and dementia (Zovoilis et al., 2011) . In 2010, O'Connor and colleagues reported that chronic immobilization stress altered miR-34c levels in the hippocampus of rats (O'Connor et al., 2012) . Subsequently, back to back reports by Haramati et al. and Zovoilis et al. showed, respectively , that miR-34c represses stress-induced anxiety and is a novel target for the treatment of dementias. In our study, we found a significant up-regulation of miR-34c-5p that negatively correlates with the expression of SAT1 in the brain of depressed suicide completers. Of interest, immobilization stress in rats clearly alters brain levels of polyamines, which are generally seen as a stress-response system (Gross, 2013) .
Very little is known about the functions of miR-320c and miR-139-5p, other than their mutual association with cancer and Prion diseases. Here, we show report an up-regulation in the levels of both miRNAs that is negatively correlated to expression levels of SAT1 and SMOX in the brains of depressed suicide completers, suggesting a relationship between their expression and polyamine regulation. Furthermore, not only was miR-320c found to be the most significant miRNA in our study, it also showed the strongest correlation with the expression of both SAT1 and SMOX, suggesting its involvement in the regulation of both genes. Interestingly, according to the centralized microRNA database (miRBase), miR-320c is the only miRNA that shows lower evolutionary conservation across species, and it is only expressed in humans and monkeys (Kozomara and Griffiths-Jones, 2011) . Taken together these results suggest that expression of these miRNAs might have a key role in normal cognitive functions in human.
To our knowledge, this is the first study to associate altered expression of miRNAs with polyamines, MDD and suicide. As previously mentioned, other studies have shown altered expression levels of several miRNAs in individuals affected with schizophrenia, bipolar disorder and MDD. Dysregulation of miRNAs have also been reported in response to anxiety and chronic stress, both of which are predisposing factors for mood disorders and increase the risk of suicidal behaviours (Haramati et al., 2011) . As this is a new and emerging field there is conflicting data regarding which miRNAs are implicated and dysregulated in psychiatric disorders, as well as the degree to which these are altered. Perhaps this can be explained by the different methodologies used across experiments. In this study, we capture subtle differences among groups by using a sensitive and accurate method for miRNA target analysis. We measured miRNA expression levels by qRT-PCR with miRNA TaqMan probes, considered to be the gold standard for miRNA quantification due to the superior sensitivity and linear dynamic range over northern blotting and microarrays (Chen et al., 2005) . Another possible explanation for conflicting reports across groups might be the type and source of tissue being used. Post-mortem tissue studies can be confounded by tissue quality and source. In this study, we used anatomically homogenous samples with high-quality of RNA. In addition, we controlled for the effects of RNA integrity, sex, age, race, pH and refrigeration delay, each of which are important confounding variables. Moreover, we performed methodical post-mortem examinations on all subjects in an attempt to obtain the most relevant information, particularly, medical history and toxicology analyses at time of death. No significant effect of these potential confounders was identified in this study.
Our results provide new evidence for alternative mechanisms associated with altered polyamine gene expression. Based on previous studies in the field it is tempting to speculate that miRNA networks are activated by stress as a response mechanism. Nevertheless, persistent exposure to stress could lead to exaggerated miRNA expression changes that could, in turn, lead to maladaptation. However, this study is not without limitations. As with other postmortem brain studies, technical limitations were present and include: small sample size, the use of frozen tissue, and demographic variables that we cannot control. It is also possible that our conservative method for miRNA target recognition excluded miRNAs that may also be responsible for the altered expression of SAT1 and SMOX. Another limitation of our study is the lack of evidence at the protein level to support our mRNA findings. Our SAT1 and SMOX results are limited to mRNA measurements. Such validation would strengthen the pharmacological significance of SAT1 and SMOX in MDD and suicide. Finally, additional experiments are required in order to experimentally validate the interaction between these miRNAs and their targets. This work should also investigate the mechanisms responsible for changes in miRNA expression and perhaps the involvement of cellular miRNA machinery in polyamine gene expression in the context of MDD and suicide. Similarly, additional experiments should investigate the role of miRNAs in the expression of other genes in the polyamine metabolic pathway.
This study suggests a relationship between miRNAs and polyamine gene expression in suicide behaviours and postulates a mechanism for SAT1 and SMOX down-regulation by post-transcriptional activity of miRNAs. In the CNS, many types of stressors rapidly activate the polyamine stress response (PSR). Regardless of type, persistent stressors have been shown to cause long-lasting changes in polyamine levels (Gilad and Gilad, 2003) . With the current findings in mind, it is tempting to speculate that the dynamic nature of the PSR may be associated with miRNA networks that respond to stress as an adaptive mechanism. Together, miRNAs and the PSR would work to counteract persistent stressful events that are directly linked to depression and suicide. Ultimately, our results provide new evidence for the role of miRNAs in neuropsychiatric disorders and a better understanding of the etiology of suicide. Moreover, this may represent an important mechanism involved in the development of MDD and suicidal behaviours that could eventually constitute novel therapeutic targets.
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